MDS Pharma Services
13
0
0
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
38%
5 trials in Phase 3/4
15%
2 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Role: collaborator
Comparative Atorvastatin Pleiotropic Effects
Role: collaborator
A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
Role: collaborator
Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers
Role: collaborator
An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
Role: collaborator
PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects
Role: collaborator
A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.
Role: collaborator
Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain
Role: collaborator
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
Role: collaborator
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
Role: collaborator
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Role: collaborator
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
Role: collaborator
A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function
Role: collaborator
All 13 trials loaded